Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Bitten by Disney sharks, Roy Scott beats the odds with Healthy Hip Hop
When a potentially life-altering business deal suddenly vanished, Roy Scott didn’t get mad — he got funded. “Disney thought they were going to snuff us out, but all they did was put gasoline on this fire,” said Scott, founder of Kansas City-based H3 Enterprises (Healthy Hip Hop). Rewind. Starting his company with a live performance-based…
Governor-in-waiting talks startup funding, Amazon and why entrepreneurism is bigger than KC
The strongest person in the room isn’t necessarily the loudest, Jeff Colyer said. “Kansans are used to being overlooked,” he said. “My role as lieutenant governor was to be a little quieter. You give your best advice. And when decisions are made, you’re going to work to support them.” Soon, however, he’ll be the state’s…
Bus tech startup Transportant announces $11M in pre-sales at Lean Lab pitch night
School districts across North America are on board with Transportant — to the tune of $11 million in pre-sale agreements, co-founder John Styers said. The startup, which uses video-based technology to allow students, parents and school administrators to better monitor school buses, announced the milestone — $10 million over its goal of $1 million in…
Councilman introduces east side investment proposal with $15/hour wage provision
As economic development surges in pockets across Kansas City, residents and businesses on the east side shouldn’t be left behind, Scott Taylor said. “Our clock is ticking as a city on this, and we need to do more,” said Taylor, councilman for the sixth district, at-large. At a press conference Thursday, Taylor introduced a draft…